Eversheds comments on Department of Health scheme to reduce price of prescription drugs
Eversheds has commented on the UK Department of Health’s new scheme that is designed to reduce the price of prescription drugs, saying that it should be a good outcome for UK industry and the government alike.
Simon Crossley, pharmaceutical industry expert at Eversheds, said: ‘This new deal represents the end of a period of uncertainty and tough negotiation between the industry and British government as national health bodies across Europe seek to reduce the public cost of health provision amid continuing economic difficulties and austerity.
‘The new PPRS [Pharmaceutical Price Regulation Scheme] should represent a good outcome for both stakeholders with the government securing savings to the UK’s drugs bill and the pharmaceutical industry avoiding the prospect of an enforced regime had agreement not been reached.’
News from Eversheds
News from The Lawyer
Briefings from Eversheds
The notion of ‘gross negligence’ is an important matter for customers and institutions alike and has been reviewed by the High Court and Supreme Court in deciding a recent case.
This report includes an analysis of the results of Eversheds survey on the Employment Tribunal process, which is based on 180 responses.
Analysis from The Lawyer
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe
Could Slater & Gordon achieve its stated aim of becoming a top consumer brand by acquiring Pannone?